27 June 2023 - Commonwealth claims on the damages undertaking remain a live issue for patentees and generics to consider. ...
21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...
19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...
31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...
4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...
29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...
26 March 2017 - In the recent decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis, Justice Stephen Burley of the Federal ...
16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...
29 April 2016 - Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property ...
29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Australia, which is also slowing access ...